Eco Animal Health Group PLC
EAH
Company Profile
Business description
Eco Animal Health Group PLC is manufacturing and supply animal health products globally. It has presence in Corporate/UK, China & Japan, North America, S & SE Asia, Latin America, Europe, and Rest of World. Majority of revenue comes from North America. Its solution includes Aivlosin is a proprietary, patented medication which is effective against both respiratory and enteric diseases in pigs and poultry; ECOVAXXIN MS a poultry vaccine targeting Mycoplasma synoviae; Parasite Solutions Internal and external parasites can cause a variety of health problems in all animal.
Contact
The Grange, 100 High street
Southgate
LondonN14 6BN
GBRT: +44 2084478899
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
213
Stocks News & Analysis
stocks
The 10 best US companies to invest in now
The stocks of these high-quality companies look cheap today.
stocks
Surge in combat drones drives upgrade for ASX share
Drone demand powers growth but investor optimism is overdone.
stocks
Meta: Meta launches enterprise offering to open up another way to monetize AI investments
The market’s negative reaction to the announcement signals that investors, much like us, are not super excited about Meta’s prospects in the enterprise market.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,854.70 | 60.30 | 0.69% |
| CAC 40 | 7,897.19 | 61.88 | 0.79% |
| DAX 40 | 25,231.20 | 291.85 | 1.17% |
| Dow JONES (US) | 51,162.19 | 235.63 | 0.46% |
| FTSE 100 | 10,461.95 | 33.68 | 0.32% |
| HKSE | 23,972.29 | 640.98 | -2.60% |
| NASDAQ | 27,168.71 | 297.11 | 1.11% |
| Nikkei 225 | 68,309.46 | 647.26 | -0.94% |
| NZX 50 Index | 13,680.49 | 130.02 | -0.94% |
| S&P 500 | 7,719.88 | 53.43 | 0.70% |
| S&P/ASX 200 | 8,682.10 | 67.70 | 0.79% |
| SSE Composite Index | 3,842.19 | 11.74 | 0.31% |